Qiagen N.V. (LON:0RLT)

Market Cap	7.67B
Revenue (ttm)	1.55B
Net Income (ttm)	72.50M
Shares Out	n/a
EPS (ttm)	0.33
PE Ratio	105.73
Forward PE	20.15
Dividend	1.23 (2.99%)
Ex-Dividend Date	Jul 2, 2025

Volume	15,937
Average Volume	67,825
Open	40.98
Previous Close	41.13
Day's Range	40.76 - 41.45
52-Week Range	34.39 - 48.29
Beta	0.67
RSI	56.39
Earnings Date	Jul 28, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RLT

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD